Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4634487
Max Phase: Preclinical
Molecular Formula: C27H26FN5O4S
Molecular Weight: 535.60
Molecule Type: Unknown
Associated Items:
ID: ALA4634487
Max Phase: Preclinical
Molecular Formula: C27H26FN5O4S
Molecular Weight: 535.60
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ccc2nc(NC(=O)CN3CCN(c4cc5c(cc4F)c(=O)c(C(=O)O)cn5C4CC4)CC3)sc2c1
Standard InChI: InChI=1S/C27H26FN5O4S/c1-15-2-5-20-23(10-15)38-27(29-20)30-24(34)14-31-6-8-32(9-7-31)22-12-21-17(11-19(22)28)25(35)18(26(36)37)13-33(21)16-3-4-16/h2,5,10-13,16H,3-4,6-9,14H2,1H3,(H,36,37)(H,29,30,34)
Standard InChI Key: XYVDPEBVRCPGSY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 535.60 | Molecular Weight (Monoisotopic): 535.1690 | AlogP: 3.85 | #Rotatable Bonds: 6 |
Polar Surface Area: 107.77 | Molecular Species: ACID | HBA: 8 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 5.60 | CX Basic pKa: 4.45 | CX LogP: 3.96 | CX LogD: 2.21 |
Aromatic Rings: 4 | Heavy Atoms: 38 | QED Weighted: 0.39 | Np Likeness Score: -1.92 |
1. Suaifan GARY, Mohammed AAM.. (2019) Fluoroquinolones structural and medicinal developments (2013-2018): Where are we now?, 27 (14): [PMID:31182257] [10.1016/j.bmc.2019.05.038] |
2. Gao F, Wang P, Yang H, Miao Q, Ma L, Lu G.. (2018) Recent developments of quinolone-based derivatives and their activities against Escherichia coli., 157 [PMID:30193220] [10.1016/j.ejmech.2018.08.095] |
Source(1):